Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

pembrolizumab 24 Paclitaxel 20 Carboplatin 19 Taxes 7 temsirolimus 6 Trastuzumab 6 Topotecan 5 Radiotherapy 5 Cisplatin 5 atezolizumab 4 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Biopsy 4 Bevacizumab 4 olaparib 3 lenvatinib 3 dostarlimab 3 Sirolimus 3 Pemetrexed 3 Irinotecan 3 Interleukin-12 Subunit p35 3 Fulvestrant 3 Cetuximab 3 Albumin-Bound Paclitaxel 3 spartalizumab 2 gedatolisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Endometrial Neoplasms × Megestrol × Clear all

NCT05332483 2023-11-03

MA-EEC

Sunnybrook Health Sciences Centre

Phase 1 Terminated

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡